The MS Australia Clinical Trials Network was established to facilitate the advancement of improved treatments for MS through clinical trials in Australia. It serves as the primary resource for individuals interested in participating in or conducting trials and research studies, as well as for updates on MS clinical research and trial activity.
The goal of the MS Australia Clinical Trials Network is to streamline the process of conducting MS clinical trials in Australia, making it a straightforward location for such trials, and to enhance accessibility to information and trial opportunities for individuals with MS and other demyelinating diseases.
The MS Australia Clinical Trials Network does not aim to replace direct interaction between trial sponsors and neurologists or individual trial sites. Instead, its purpose is to facilitate connections and enhance the exchange of information.
MS Clinical Trials Network is coordinated by MS Australia. The Network’s Executive Committee consists of MS neurologist representatives from Australia and New Zealand, supported by a Scientific Review Committee.
"*" indicates required fields